Drug Extravasation in Cancer Chemotherapy

Letters and Corrections1 January 1986Drug Extravasation in Cancer ChemotherapyJACOB J. LOKICH, M.D., CHERIE MOORE, R.N.JACOB J. LOKICH, M.D.Search for more papers by this author, CHERIE MOORE, R.N.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-104-1-124_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Reed and colleagues (1) have reported their experience with drug extravasation developing in five of ten patients in whom venous access ports were used for the delivery of dobutamine or cancer chemotherapy. They conclude that use of venous access ports should perhaps be limited to infusions of short duration, defined as less than 1 to 2 hours. Although the mechanism was not detailed in the report, they suggest that the development of extravasation was related to dislodgement of the needle from the access port.We have used venous access devices in 195 patients in whom we placed...References1. REEDNEWMANAPPLEFELDSUTTON WKMF. Drug extravasation as a complication of venous access ports. Ann Intern Med. 1985;102:788-90. LinkGoogle Scholar2. LOKICHBOTHEBENOTTIMOORE JAPC. Complications and management of implanted venous access catheters. J Clin Oncol. 1985;3:710-7. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New England Deaconess Hospital Boston, MA 02215 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byTreatment of anthracycline extravasation from centrally inserted venous cathetersManagement of Chemotherapeutic Agent Extravasation and Radiation Therapy Adverse EffectsDexrazoxane for anthracycline extravasationMeasuresPrevention and Management of Antineoplastic Extravasation InjuryCurrent treatment options for catheter-related thrombosisRare complications of vascular access devicesLong-term central venous catheters: Issues for carePrevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approachImplantable Devices in Patients with Haematological DiseasesConservative Approach to the Treatment of Chemotherapy-Induced ExtravasationExtravasation of Doxorubicin from Vascular Access DevicesExtravasation management 1 January 1986Volume 104, Issue 1Page: 124-124KeywordsCancer chemotherapyDrug deliveryDrugs Issue Published: 1 January 1986 PDF downloadLoading ...